Clinical Program Courses - PharmD

PP 501 - Community Pharmacy Practice (2+1)
This course includes the study of the clinical situations that can be handled by the pharmacist in the community pharmacy (referral or using OTC medications) including upper respiratory tract, gastrointestinal, and musculosketal symptoms, skin, eyes, and ears, and childhood symptoms.

PP 602 - Hospital Pharmacy (2+1)
Organization and structure of a hospital pharmacy, hospital pharmacy facilities and services (inpatient and outpatient services), transfer of care, patient’s medication record, and rational medication use, hospital formulary, pharmacy and therapeutic committee, I.V. admixtures and incompatibilities, parenteral nutrition, handling of cytotoxic drugs, therapeutic drug monitoring, patient counselling and safety, and risk management

PP 603 - Clinical Pharmacy Practice (2+1)
This course includes the definition and concepts of clinical pharmacy and pharmaceutical care, case history and case presentation, medication history taking, clinical problem solving, and therapeutic planning, clinical rounding and assessment of patient compliance. Principles of special care populations (geriatric, pediatric, pregnancy, and lactation). Drug-related problems and drug interactions . Interpretation of clinical laboratory data and physical examination.

PP 704 - Drug information (1+1)
This course includes an advanced application of the science of drug information in terms of: its practice within the drug information centers and various clinical sites. The course will focus on Drug information and poison information centers, different drug information resources, use of the internet for drug and research information, evaluating information on the web. The classification of study design and clinical trials, data presentation, and basic statistical concepts are detailed. Basics of pharmacoeconomic literature are described.

PP 805 - Management of endocrine & renal diseases (1+1)
This course includes the Pathophysiology, causes, clinical presentation, diagnosis and application of pharmaceutical care plans in different endocrinologic disorders (Diabetes, thyroid disorder, caushing syndrome,...) and different renal disorders and related fluid and electrolyte disturbances (acute and chronic renal failure, uremic syndrome, kidney stones, ..). The course develops the students’ ability to design, monitor, refine safe and cost-effective treatment plans and provide appropriate information to patient, caregivers, and health professionals.

PP 806 - Management of oncological diseases and radio pharmacy (2+1)
Cancer aetiology, risk factors, cancer staging and grading, diagnosis, prognosis, optimizing chemotherapeutic regimens, different types of tumours (solid and hematologic) and their management, toxicities of chemotherapy, supportive treatment, pharmaceutical care and patient's support measures. This course also includes studying radioactive isotopes which process medical applications and precautions of their usage.

PP 807 - Clinical Pharmacokinetics (2+1)
Introduction to clinical pharmacokinetics and its applications, pharmacokinetics, non-compartmental pharmacokinetics and moment analysis. Drug distribution and drug clearance mechanisms, IV infusion kinetics and kinetics following extra-vascular dosing, metabolite kinetics, multiple dose kinetics, non-linear pharmacokinetics, dosage regimen design, dosage individualization of drugs of narrow therapeutic index especially in patients with compromised renal and hepatic function.

PP 908 - Management of neuropsychiatry diseases (1+1)
This course aims to provide the student with the knowledge in, pathophysiology, clinical interpretation, pharmacotherapy and management of neuropsychiatric diseases (e. .g mental health disorders, schizophrenia, depression, anxiety, seizure disorders, parkinsonism, migraines, dementia and Alzheimer's disease). Sedative and hypnotics, general anesthetics, opioid analgesics and non steroidal anti-inflammatory drugs.

PP 909 - Clinical Nutrition (1+1)
Measures of healthy life-style – Macronutrients and calculation of calories – Basal metabolic rate (BMR) - Rcommended daily allowance (RDA) – Nutritional requirement for pediatrics and geriatrics - Vitamins and minerals (role in metabolism – clinical significance) – Gut microbiota and human health – Enteral and parenteral nutrition - Dietary care for patients with obesity, diabetes mellitus, cardiovascular, renal and hepatic disorders – Dietary care for cancer patients - Dietary care for sports` men - Dietary care for pregnant and lactating women – Nutrigenomics.

PP 010 - Management of critical care patients (1+1)
This course aims to provide the student with the knowledge in, pathophysiology, clinical interpretation, pharmacotherapy and management of critical care illness (e.g. medical and surgical crises, trauma patients, supportive care, ICU infections, burns, neuro-critical care, cardiovascular critical care, sepsis, septic shock, pain and analgesia, bleeding disorders and anticoagulation, nutritional support and therapy, hemodynamic monitoring, fluid and electrolyte disorders).

PP 011 - Management of dermatological, reproductive and musculoskeletal diseases (2+1)
Skin structure and function, primary and secondary lesions. Most popular skin diseases: infective and non-infective types and their differentiation. Sexually transmitted diseases, male infertility, and women health. Musculoskeletal disorders are also included.

PP 012 - Management of Pediatric diseases (2+1)
Nutritional requirements in neonates and infants, nutritional disorders, neonatology, infectious diseases in pediatrics, congenital heart diseases, endocrine, neurological, haematologic, renal, and respiratory disorders, pediatric emergencies.

PP 013 - Management of Cardiovascular diseases (2+1)
Main diseases affecting the cardiovascular system, symptoms, prognosis, pharmacological and non-pharmacological management, patient counseling and monitoring of dyslipidaemias, hypertension, coronary artery disease, acute coronary syndromes, heart failure, dysrhythmias, thromboembolic disorders, and stroke.

PP 014 - Management of Gastrointestinal diseases (2+1)
Hepatic disorders including viral hepatitis, pancreatitis, gastrointestinal bleeding, peptic ulcer, gastro-esophageal reflux disease, inflammatory bowel diseases and irritable bowel syndrome as well as gastrointestinal symptoms including nausea, vomiting, constipation, and diarrhea.

PP 015 - Management of Respiratory diseases (1+1)
Epidemiology, aetiology, pathophysiology, clinical manifestation, investigations, treatment, monitoring, and patient counseling of bronchial asthma, chronic obstructive pulmonary disease, pulmonary hypertension, cystic fibrosis, upper and lower respiratory tract infections, and drug-induced respiratory problems.

PP 016 - Clinical Research and Pharmacovigilance (1+0)
This course introduces the student to the basic principles of clinical research, design of research studies, types of research studies, clinical trials, statistical presentation of research data and ethical guidelines in drug research. This course also provides the student's with understanding of pharmacovigilance importance, concept, processes, systems, global safety standards and regulations and reporting systems.

PP E17 - Geriatric pharmacotherapy (1+1)
Geriatric Therapeutics is designed to prepare the student to provide pharmaceutical care to the elderly patient. The course is composed of 3 sections covering general principles of aging and geriatric assessment skills, followed by the pharmacotherapy of selected disease states and syndromes common to the senior population and ending with geriatric & consultant pharmacy practice. At completion of this course, the successful student will be able to:
1. Describe the biology of aging and discuss common theories of aging.
2. Perform selected aspects of physical and psychiatric assessment utilizing tools developed for the geriatric patient to identify those with the highest risk for medicationrelated problems.
3. Effectively communicate with elderly patients using appropriate sources of patient education information.
4. Describe drug regimen review and regulations involving consultantpharmacy practice.
5. Evaluate therapeutic decisions and preventive care given a patient’s life expectancy and available evidence for benefit.

PP E18 - Interprofessional skills (1+1)
By the end of this course students will be able to:
1) Describe the philosophy of interprofessional practice;
2) Describe the role of other professionals and their roles and responsibilities in patient care and in the health of populations;
3) Explore methods of interprofessional collaboration with others;
4) Appreciate the relevance and impact of ethics in interprofessional practice;
5) Apply appropriate communication skills with team members, patients and individuals involved in patient care or health promotion.

PP E19 - Pharmacoeconomics (1+1)
The purpose of this course is to introduce students to the fundamental methods ofpharmacoeconomic analysis. Topics include the terminology used in pharmacoeconomics, research methods frequently used in pharmacoeconomics, and the role of pharmacoeconomics in the drug development process and health care decision making relevant to the practice of pharmacy, cost/benefit assessment, public health systems, health insurance, tax-based systems. These principles will prepare the student for future coursework where the student will develop and implement individualized treatment plans, taking into consideration pharmacoeconomics factors.